Løfling, L. Lukas http://orcid.org/0000-0002-2731-8532
Støer, Nathalie C.
Sloan, Erica K. http://orcid.org/0000-0002-2355-1433
Chang, Aeson
Gandini, Sara
Ursin, Giske
Botteri, Edoardo http://orcid.org/0000-0002-9023-8068
Article History
Received: 14 February 2022
Revised: 7 June 2022
Accepted: 8 June 2022
First Online: 20 June 2022
Competing interests
: ES is a scientific advisory board member for Cygnal Therapeutics. The other authors have no competing interests.
: The study received ethical approval from the Regional Committee for Medical and Health Research Ethics Sør-Øst (S-09113b 2009/2062, 2014/1854/REK sør-øst B) and from the Norwegian Data Protection Authority (17/00222–4/GRA).